Home
Scholarly Works
2249P Baseline methylthioadenosine (MTA) levels as...
Journal article

2249P Baseline methylthioadenosine (MTA) levels as potential prognostic markers in metastatic pancreatic ductal adenocarcinoma (mPDAC): An exploratory analysis of CCTG PA.7 trial

Authors

Harvey HM; Titmuss E; Topham J; Renouf DJ; Knox J; Kavan P; Jonker D; Welch SA; Couture F; Lemay F

Journal

Annals of Oncology, Vol. 36, ,

Publisher

Elsevier

Publication Date

September 1, 2025

DOI

10.1016/j.annonc.2025.08.2866

ISSN

0923-7534

Contact the Experts team